Analyst Ratings

Upgrades, downgrades, and outlook changes from major analysts.

Coverage of analyst actions including upgrades, downgrades, initiations, and price-target changes. This category tracks how institutional research influences market perception, momentum shifts, and short-term price behavior.

Articles

3,519 total articles

Truist Increases Gilead Sciences Price Target to $152 Following Strong Q4; Highlights HIV Franchise and Upcoming Catalysts

Truist Increases Gilead Sciences Price Target to $152 Following Strong Q4; Highlights HIV Franchise and Upcoming Catalysts

Truist Securities raised its price target on Gilead Sciences to $152 from $145 and kept a Buy rating after the company reported Q4 2025 results that outperformed consensus on revenue and adjusted EPS. The upgrade reflects confidence in Gilead’s HIV franchise and a pipeline of upcoming catalysts, though some investor debate over Yeztugo’s $800 milli…

Bernstein Lifts Gilead Price Target to $160 After Q4 Beat, Cites Upside Despite Conservative Guidance

Bernstein Lifts Gilead Price Target to $160 After Q4 Beat, Cites Upside Despite Conservative Guidance

Bernstein SocGen Group raised its price target on Gilead Sciences to $160 from $135 and maintained an Outperform rating after the company reported fourth-quarter revenue and adjusted EPS above certain consensus estimates. Gilead issued fiscal 2026 guidance that came in marginally below consensus midpoints for product revenue and adjusted EPS, yet B…

Bernstein Sticks With Outperform on Robinhood Despite Crypto Drag

Bernstein Sticks With Outperform on Robinhood Despite Crypto Drag

Bernstein SocGen Group has reaffirmed an Outperform rating and a $160 price target on Robinhood Markets (HOOD) following the company's fourth-quarter earnings. The broker notes that a shortfall in crypto revenue, which it had expected, drove the revenue miss, but it views the weakness as temporary and highlights growth in prediction markets and oth…

Evercore Lowers MNTN Price Target to $27 Despite Strong Q4 Results

Evercore Lowers MNTN Price Target to $27 Despite Strong Q4 Results

Evercore ISI cut its price target for MNTN Inc to $27 from $33 but kept an Outperform rating, citing lower EV/EBITDA multiples across small- and mid-cap internet peers. The adjustment follows a quarter in which MNTN posted accelerating organic revenue growth, expanding adjusted EBITDA margins, and guidance that topped consensus at the midpoint.

Goldman Sachs Reaffirms Sell on BlackLine, Sets $44 Target as Growth Sustainability Concerns Persist

Goldman Sachs Reaffirms Sell on BlackLine, Sets $44 Target as Growth Sustainability Concerns Persist

Goldman Sachs has kept a Sell rating on BlackLine (NASDAQ:BL) with a $44.00 price objective, pointing to doubts about the company’s ability to sustain its recent growth trajectory. BlackLine shares are trading near their 52-week low after a year of significant decline, while the company reported mixed results with some revenue beats and improving r…

Goldman Sachs Lifts Duke Energy Price Target to $142, Cites Expanded Capital Plan and Rate-Base Growth

Goldman Sachs Lifts Duke Energy Price Target to $142, Cites Expanded Capital Plan and Rate-Base Growth

Goldman Sachs increased its price target on Duke Energy to $142 from $141 while retaining a Buy recommendation. The firm highlighted a sizable expansion in Duke’s capital plan and stronger rate-base growth expectations through 2030, and projects average earnings growth of roughly 8% through that period. Recent quarterly results modestly beat foreca…

TD Cowen Lowers Lyft Price Target to $30 After Rides Growth Miss

TD Cowen Lowers Lyft Price Target to $30 After Rides Growth Miss

TD Cowen trimmed its price target for Lyft to $30 from $32 while keeping a Buy rating after the ride-hailing company's fourth-quarter report showed solid bookings and EBITDA but weaker-than-expected rides growth. The results and commentary prompted several other brokerages to reduce their targets amid concerns about ride volume and competitive pres…